EN
ANIVA LAUNCHES EYEASPIS Re-D

Aniva International launches the first supplement EYEASPIS Re-D dedicated to the management of Diabetic Retinopathy. As always remaining dedicated to its mission Aniva brings in the market the 3rd medical intervention dedicated to autoimmune and chronic diseases.

SHARE
BACK TO NEWS

Leave a Comment

Your email address will not be published. Required fields are marked *